FICZ generates human tDCs that induce CD4 CD25high Foxp3 Treg-like cell differentiation
Article
-
- Overview
-
- Research
-
- Identity
-
- Additional Document Info
-
- View All
-
Overview
abstract
-
Dendritic cells (DCs) play a central role in the maintenance of immune homeostasis, their participation as professional antigen presenting cells is essential to the initiation of the adaptive immune response as well as to the induction of tolerance. The recently described role of the aryl hydrocarbon receptor (AhR) in the immune system, particularly in the modulation of the adaptive immune response has attracted the attention as a potential player in the induction of immune tolerance. However, the effects of AhR activation through endogenous ligands on human DCs have been poorly evaluated. In this study, we investigated the effect of FICZ, a natural AhR ligand, on monocyte-derived dendritic cells (Mo-DCs) from healthy subjects. We found that the activation of AhR through FICZ during DCs differentiation and maturation processes resulted in a decreased expression of CD83, an increased expression of the enzyme IDO and a reduced production of the pro-inflammatory cytokines IL-6 and TNF-α. More importantly, FICZ-treated DCs were able to induce the differentiation of naive T lymphocytes into CD4 CD25high Foxp3 T reg-like cells. Our results show that the activation of the AhR on human DCs induces a tolerogenic phenotype with potential implications in immunotherapy. © 2017 European Federation of Immunological Societies
-
Dendritic cells (DCs) play a central role in the maintenance of immune homeostasis, their participation as professional antigen presenting cells is essential to the initiation of the adaptive immune response as well as to the induction of tolerance. The recently described role of the aryl hydrocarbon receptor (AhR) in the immune system, particularly in the modulation of the adaptive immune response has attracted the attention as a potential player in the induction of immune tolerance. However, the effects of AhR activation through endogenous ligands on human DCs have been poorly evaluated. In this study, we investigated the effect of FICZ, a natural AhR ligand, on monocyte-derived dendritic cells (Mo-DCs) from healthy subjects. We found that the activation of AhR through FICZ during DCs differentiation and maturation processes resulted in a decreased expression of CD83, an increased expression of the enzyme IDO and a reduced production of the pro-inflammatory cytokines IL-6 and TNF-α. More importantly, FICZ-treated DCs were able to induce the differentiation of naive T lymphocytes into CD4%2b CD25high Foxp3%2b T reg-like cells. Our results show that the activation of the AhR on human DCs induces a tolerogenic phenotype with potential implications in immunotherapy. © 2017 European Federation of Immunological Societies
publication date
funding provided via
published in
Research
keywords
-
Aryl hydrocarbon receptor; FICZ; IDO; Tolerance; Tolerogenic dendritic cells; Treg cells 6 formylindolo(3,2 b)carbazole; aromatic hydrocarbon receptor; carbazole derivative; CD4 antigen; CD83 antigen; immunomodulating agent; indoleamine 2,3 dioxygenase; interleukin 2 receptor alpha; interleukin 6; ligand; transcription factor FOXP3; tumor necrosis factor; unclassified drug; 6-formylindolo(3,2-b)carbazole; aromatic hydrocarbon receptor; carbazole derivative; CD4 antigen; forkhead transcription factor; FOXP3 protein, human; interleukin 2 receptor alpha; interleukin 6; tumor necrosis factor; antigen expression; Article; CD4 CD25high Foxp3 regulatory T lymphocyte; cell maturation; controlled study; cytokine production; dendritic cell; drug mechanism; human; human cell; immunotherapy; lymphocyte differentiation; monocyte; phenotype; priority journal; protein expression; protein synthesis regulation; regulatory T lymphocyte; agonists; cell culture; cell differentiation; coculture; dendritic cell; immunological tolerance; immunology; lymphocyte activation; metabolism; procedures; regulatory T lymphocyte; Carbazoles; CD4 Antigens; Cell Differentiation; Cells, Cultured; Coculture Techniques; Dendritic Cells; Forkhead Transcription Factors; Humans; Immune Tolerance; Immunotherapy; Interleukin-2 Receptor alpha Subunit; Interleukin-6; Lymphocyte Activation; Monocytes; Receptors, Aryl Hydrocarbon; T-Lymphocytes, Regulatory; Tumor Necrosis Factor-alpha
-
Aryl hydrocarbon receptor; FICZ; IDO; Tolerance; Tolerogenic dendritic cells; Treg cells 6 formylindolo(3,2 b)carbazole; aromatic hydrocarbon receptor; carbazole derivative; CD4 antigen; CD83 antigen; immunomodulating agent; indoleamine 2,3 dioxygenase; interleukin 2 receptor alpha; interleukin 6; ligand; transcription factor FOXP3; tumor necrosis factor; unclassified drug; 6-formylindolo(3,2-b)carbazole; aromatic hydrocarbon receptor; carbazole derivative; CD4 antigen; forkhead transcription factor; FOXP3 protein, human; interleukin 2 receptor alpha; interleukin 6; tumor necrosis factor; antigen expression; Article; CD4+ CD25high Foxp3+ regulatory T lymphocyte; cell maturation; controlled study; cytokine production; dendritic cell; drug mechanism; human; human cell; immunotherapy; lymphocyte differentiation; monocyte; phenotype; priority journal; protein expression; protein synthesis regulation; regulatory T lymphocyte; agonists; cell culture; cell differentiation; coculture; dendritic cell; immunological tolerance; immunology; lymphocyte activation; metabolism; procedures; regulatory T lymphocyte; Carbazoles; CD4 Antigens; Cell Differentiation; Cells, Cultured; Coculture Techniques; Dendritic Cells; Forkhead Transcription Factors; Humans; Immune Tolerance; Immunotherapy; Interleukin-2 Receptor alpha Subunit; Interleukin-6; Lymphocyte Activation; Monocytes; Receptors, Aryl Hydrocarbon; T-Lymphocytes, Regulatory; Tumor Necrosis Factor-alpha
Identity
Digital Object Identifier (DOI)
PubMed ID
Additional Document Info
start page
end page
volume